Detalhe da pesquisa
1.
Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum.
Clin Infect Dis
; 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180851
2.
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet
; 397(10281): 1276-1292, 2021 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812487
3.
Prevalence of detectable HIV-DNA and -RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.
AIDS
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38814693
4.
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014.
J Acquir Immune Defic Syndr
; 92(2): 153-161, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36215957
5.
Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014.
J Pediatric Infect Dis Soc
; 12(12): 602-609, 2023 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37815035
6.
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet HIV
; 10(6): e363-e374, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167996
7.
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.
Lancet HIV
; 10(8): e506-e517, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541705
8.
Forty-Eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth With HIV in the United States.
J Acquir Immune Defic Syndr
; 91(3): 296-304, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839439
9.
Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States.
J Acquir Immune Defic Syndr
; 88(5): 497-505, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34483297